Thrombotic risk minimization for Diane-35 and generics.

Irene D BezemerElisabeth SmitsFernie J A Penning-van BeestAlex AsiimweRon M C Herings

Published in: Pharmacoepidemiology and drug safety (2017)

This descriptive analysis showed similar proportions of CPA/EE users examined with acne or other hyperandrogenic conditions, or with recent acne treatment, or concomitant dispensing of other HC in the Netherlands before and after the referral procedure. The key observation was a strong overall reduction of CPA/EE use in the Netherlands.

Keyphrases

hidradenitis suppurativa
primary care
minimally invasive
combination therapy
data analysis